Using an animal model to predict the effective human dose for oral multiple sclerosis drugs
Abstract The objective of this study was to determine the potential usefulness of an animal model to predict the appropriate dose of newly developed drugs for treating relapsing remitting multiple sclerosis (RRMS). Conversion of the lowest effective dose (LEffD) for mice and rats in the experimental...
Main Authors: | Wei Liu, Zhiheng Yu, Ziyu Wang, Emmanuelle L. Waubant, Suodi Zhai, Leslie Z. Benet |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-03-01
|
Series: | Clinical and Translational Science |
Online Access: | https://doi.org/10.1111/cts.13458 |
Similar Items
-
Design recommendations for studies that evaluate multiple sclerosis fatigue interventions
by: Mahsa Ghajarzadeh, et al.
Published: (2024-01-01) -
Rituximab in relapsing and progressive forms of multiple sclerosis: a systematic review.
by: Tamara Castillo-Trivino, et al.
Published: (2013-01-01) -
ORAL DRUGS FOR PATHOGENETIC TREATMENT OF MULTIPLE SCLEROSIS
by: E. V. Popova, et al.
Published: (2017-07-01) -
Advance in new oral drugs for multiple sclerosis
by: Guan⁃en ZHOU, et al.
Published: (2012-04-01) -
The value of animal models for drug development in multiple sclerosis.
by: Friese, M, et al.
Published: (2006)